These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21980194)

  • 21. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.
    Shi ZS; Loh Y; Walker G; Duckwiler GR;
    Stroke; 2010 Jun; 41(6):1185-92. PubMed ID: 20431084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke?
    Kass-Hout T; Kass-Hout O; Mokin M; Thesier DM; Yashar P; Orion D; Jahshan S; Hopkins LN; Siddiqui AH; Snyder KV; Levy EI
    World Neurosurg; 2014; 82(3-4):e453-8. PubMed ID: 23376392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G
    Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke.
    Arnold M; Mattle S; Galimanis A; Kappeler L; Fischer U; Jung S; De Marchis GM; Gralla J; Mono ML; Brekenfeld C; Meier N; Nedeltchev K; Schroth G; Mattle HP
    Int J Stroke; 2014 Dec; 9(8):985-91. PubMed ID: 22973986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
    Alonso de Leciñana M; Fuentes B; Masjuan J; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Egido JA
    Int J Stroke; 2012 Apr; 7(3):213-8. PubMed ID: 22098785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromobolysis for acute ischemic stroke: is intra-arterial better than intravenous? A treatment effects model.
    Powers WJ
    J Stroke Cerebrovasc Dis; 2012 Jul; 21(5):401-3. PubMed ID: 22464277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
    Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
    Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial.
    Fransen PS; Berkhemer OA; Lingsma HF; Beumer D; van den Berg LA; Yoo AJ; Schonewille WJ; Vos JA; Nederkoorn PJ; Wermer MJ; van Walderveen MA; Staals J; Hofmeijer J; van Oostayen JA; Lycklama À Nijeholt GJ; Boiten J; Brouwer PA; Emmer BJ; de Bruijn SF; van Dijk LC; Kappelle LJ; Lo RH; van Dijk EJ; de Vries J; de Kort PL; van den Berg JS; van Hasselt BA; Aerden LA; Dallinga RJ; Visser MC; Bot JC; Vroomen PC; Eshghi O; Schreuder TH; Heijboer RJ; Keizer K; Tielbeek AV; den Hertog HM; Gerrits DG; van den Berg-Vos RM; Karas GB; Steyerberg EW; Flach HZ; Marquering HA; Sprengers ME; Jenniskens SF; Beenen LF; van den Berg R; Koudstaal PJ; van Zwam WH; Roos YB; van Oostenbrugge RJ; Majoie CB; van der Lugt A; Dippel DW;
    JAMA Neurol; 2016 Feb; 73(2):190-6. PubMed ID: 26716735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elderly patients and intra-arterial stroke therapy.
    Leslie-Mazwi TM; Chandra RV; Simonsen CZ; Yoo AJ
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1713-23. PubMed ID: 24195443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.